Tazoryth P 4000mg/500mg Injection
Marketer
Penryth Labs Private Limited
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tazoryth P 4000mg/500mg Injection
Ceftazidime/Tazobactam 4000mg/500mg injection is a dual-antibiotic therapy effective against a wide spectrum of bacterial infections. Its mechanism involves microbial eradication. Administration should always be performed by a qualified medical practitioner; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on the infection's severity. Adherence to the prescribed regimen is crucial. Potential adverse reactions may include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and localized injection site reactions (pain, swelling, erythema). Persistent or worsening side effects warrant immediate medical attention. Prior to treatment, disclose any antibiotic allergies, hepatic or renal impairments to your doctor; dosage adjustments or alternative medications may be necessary. While generally considered safe under medical guidance, its use during pregnancy and lactation requires careful monitoring by a healthcare professional.
Uses of Tazoryth P 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Tazoryth P 4000mg/500mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Tazoryth P 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazoryth P 4000mg/500mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Tazoryth P 4000mg/500mg Injection works:
The injectable drug Tazoryth P, containing 4000mg of piperacillin and 500mg of tazobactam, employs a dual-action mechanism. Piperacillin, an antibiotic, disrupts bacterial cell wall synthesis, a vital process for bacterial viability. Tazobactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby boosting piperacillin's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Tazoryth P 4000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Tazoryth P 4000mg/500mg Injection is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; however, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Tazoryth P (4000mg/500mg) presents no known breastfeeding contraindications. Research in humans indicates minimal drug transfer to breast milk, posing negligible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Tazoryth P 4000mg/500mg Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with impaired kidney function should use Tazoryth P 4000mg/500mg Injection with care; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tazoryth P 4000mg/500mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification might not be necessary; however, medical advice is recommended.
What if you forget to take Tazoryth P 4000mg/500mg Injection :
Omit a Tazoryth P 4000mg/500mg Injection dose? Seek your physician's advice.
Facts to Know About Tazoryth P 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently